文献速递皮肤肿瘤

年龄与中等厚度黑色素瘤(1.01-4.00 mm)患者淋巴结转移可能性的关系:一项美国国家癌症数据库研究

Relationship between age and likelihood of lymph node metastases in patients with intermediate thickness melanoma (1.01-4.00 mm): A National Cancer Database study.
PubMed 文献 · J Am Acad Dermatol · 2018-08-27

该回顾性队列研究利用美国国家癌症数据库分析2010至2013年间接受广泛切除和淋巴结评估的中等厚度黑色素瘤患者,共23,440例,其中14.7%存在淋巴结转移。分类与回归树分析显示,年龄大于55岁、无淋巴血管侵犯且病变厚度小于1.7 mm的患者前哨淋巴结阳性率为4.9%;在无溃疡患者中,基于年龄和厚度的模型识别出的低风险亚组前哨淋巴结阳性率为4.7%。作者认为年龄是估计前哨淋巴结风险的重要因素,可能有助于识别无溃疡且可安全避免前哨淋巴结活检的患者。

要点

  • 23,440例中等厚度黑色素瘤患者中14.7%存在淋巴结转移。
  • 年龄大于55岁、无淋巴血管侵犯且厚度小于1.7 mm者前哨淋巴结阳性率为4.9%。
  • 无溃疡患者中基于年龄和厚度的模型识别低风险亚组前哨淋巴结阳性率为4.7%。

核心结论

  • 患者年龄是估计中等厚度黑色素瘤患者前哨淋巴结风险的重要因素,可能有助于识别无溃疡且可安全避免前哨淋巴结活检的患者。

研究设计与样本

  • 回顾性队列研究,利用美国国家癌症数据库识别2010至2013年间接受广泛切除和淋巴结评估的中等厚度黑色素瘤患者,共23,440例,分析淋巴结转移情况,并采用分类与回归树分析识别低风险组。

主要发现

  • 23,440例患者中14.7%发现淋巴结转移。
  • 分类与回归树分析显示,年龄大于55岁、无淋巴血管侵犯且病变厚度小于1.7 mm的患者前哨淋巴结阳性率为4.9%。
  • 在无溃疡患者中,使用年龄和厚度的模型识别出的低风险亚组前哨淋巴结阳性率为4.7%。

临床怎么用

  • 作者认为年龄可能有助于识别无溃疡且可安全避免前哨淋巴结活检的中等厚度黑色素瘤患者。

局限性

  • 本研究为回顾性研究。
  • 所开发的模型需要前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is large variability in the risk of sentinel lymph node (SLN) positivity among patients with intermediate thickness melanoma (ITM), with a subgroup of patients exhibiting a low risk of nodal disease. OBJECTIVE: To identify a group of patients with ITM for whom the risk of nodal disease is low. METHODS: A retrospective cohort of patients with ITM who underwent wide excision and nodal evaluation from 2010 to 2013 was identified by using the National Cancer Database and analyzed for the presence of nodal disease. Classification and regression tree analysis identified the most important factors used in a model to identify groups at low risk of SLN positivity. RESULTS: Of 23,440 patients, 14.7% were found to have nodal metastasis. On classification and regression tree analysis, patients older than 55 years without lymphovascular invasion and with a lesion thickness less than 1.7 mm had an SLN positivity rate of 4.9%. A model using age and thickness in nonulcerated patients identified a low-risk subgroup with a corresponding SLN positivity rate of 4.7%. LIMITATIONS: This was a retrospective study, and the model developed requires prospective validation. CONCLUSIONS: Patient age is an important factor in estimating risk of SLN in patients with ITM and may help identify patients without ulceration who may be safely spared an SLN biopsy.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Hanna AN, Sinnamon AJ, Roses RE, et al. Relationship between age and likelihood of lymph node metastases in patients with intermediate thickness melanoma (1.01-4.00 mm): A National Cancer Database study. J Am Acad Dermatol. 2018. PMID: 30165160. doi:10.1016/j.jaad.2018.08.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。